1,141
Views
10
CrossRef citations to date
0
Altmetric
Reviews

The Duality of Fgl2 - Secreted Immune Checkpoint Regulator Versus Membrane-Associated Procoagulant: Therapeutic Potential and Implications

, , , , , & show all
Pages 325-339 | Accepted 17 Aug 2014, Published online: 26 Sep 2014

REFERENCES

  • Koyama T, Hall LR, Haser WG, Structure of a cytotoxic T-lymphocyte-specific gene shows a strong homology to fibrinogen beta and gamma chains. Proc Nat Acad Sci USA 1987;84(6):1609–1613. PubMed PMID: 3550794; PubMed Central PMCID: PMC304485.
  • Ruegg C, Pytela R. Sequence of a human transcript expressed in T-lymphocytes and encoding a fibrinogen-like protein. Gene 1995;160(2):257–262. PubMed PMID: 7642106.
  • Yuwaraj S, Ding J, Liu M, Genomic characterization, localization, and functional expression of FGL2, the human gene encoding fibroleukin: a novel human procoagulant. Genomics 2001;71(3):330–338. doi: 10.1006/geno.2000.6444. PubMed PMID: 11170750.
  • Rawlings ND, Barrett AJ. Families of cysteine peptidases. Methods Enzymol 1994;244:461–486. PubMed PMID: 7845226.
  • Barrett AJ, Rawlings ND. Families and clans of serine peptidases. Arch Biochem Biophys 1995;318(2):247–250. doi: 10.1006/abbi.1995.1227. PubMed PMID: 7733651.
  • Liu H, Yang PS, Zhu T, Characterization of fibrinogen-like protein 2 (FGL2): monomeric FGL2 has enhanced immunosuppressive activity in comparison to oligomeric FGL2. Int J Biochem Cell Biol 2012;45(2):408–418. Epub 2012/11/07. doi: S1357-2725(12)00360-3 [pii] 10.1016/j.biocel.2012.10.014. PubMed PMID: 23127799.
  • Marazzi S, Blum S, Hartmann R, Characterization of human fibroleukin, a fibrinogen-like protein secreted by T lymphocytes. J Immunol 1998;161(1):138–147. PubMed PMID: 9647217.
  • Mu J, Qu D, Bartczak A, Fgl2 deficiency causes neonatal death and cardiac dysfunction during embryonic and postnatal development in mice. Physiol Genomics 2007;31(1):53–62. doi: 10.1152/physiolgenomics.00026.2007. PubMed PMID: 17550996.
  • Shalev I, Liu H, Koscik C, Targeted deletion of fgl2 leads to impaired regulatory T cell activity and development of autoimmune glomerulonephritis. J Immunol 2008;180(1):249–260. PubMed PMID: 18097026.
  • Ning Q, Brown D, Parodo J, Ribavirin inhibits viral-induced macrophage production of TNF, IL-1, the procoagulant fgl2 prothrombinase and preserves Th1 cytokine production but inhibits Th2 cytokine response. J Immunol 1998;160(7):3487–3493. PubMed PMID: 9531310.
  • Yang C, Chen Y, Guo G, Expression of B and T lymphocyte attenuator (BTLA) in macrophages contributes to the fulminant hepatitis caused by murine hepatitis virus strain-3. Gut 2013;62(8):1204–1213. doi: 10.1136/gutjnl-2012-302239. PubMed PMID: 22637698.
  • Marsden PA, Ning Q, Fung LS, The Fgl2/fibroleukin prothrombinase contributes to immunologically mediated thrombosis in experimental and human viral hepatitis. J Clin Invest 2003;112(1):58–66. doi: 10.1172/JCI18114. PubMed PMID: 12840059; PubMed Central PMCID: PMC162293.
  • Chan CW, Kay LS, Khadaroo RG, Soluble fibrinogen-like protein 2/fibroleukin exhibits immunosuppressive properties: suppressing T cell proliferation and inhibiting maturation of bone marrow-derived dendritic cells. J Immunol 2003;170(8):4036–4044. PubMed PMID: 12682232.
  • Su K, Chen F, Yan WM, Fibrinogen-like protein 2/fibroleukin prothrombinase contributes to tumor hypercoagulability via IL-2 and IFN-gamma. World J Gastroenterol 2008;14(39):5980–5989. PubMed PMID: 18932275; PubMed Central PMCID: PMC2760190.
  • Liu M, Leibowitz JL, Clark DA, Gene transcription of fgl2 in endothelial cells is controlled by Ets-1 and Oct-1 and requires the presence of both Sp1 and Sp3. Eur J Biochem/FEBS 2003;270(10):2274–2286. PubMed PMID: 12752447.
  • Levy GA, Liu M, Ding J, Molecular and functional analysis of the human prothrombinase gene (HFGL2) and its role in viral hepatitis. Am J Pathol 2000;156(4):1217–1225. doi: 10.1016/S0002-9440(10)64992-9. PubMed PMID: 10751347; PubMed Central PMCID: PMC1876871.
  • Ding JW, Ning Q, Liu MF, Fulminant hepatic failure in murine hepatitis virus strain 3 infection: tissue-specific expression of a novel fgl2 prothrombinase. J Virol 1997;71(12):9223–9230. PubMed PMID: 9371581; PubMed Central PMCID: PMC230225.
  • Liu H, Yang PS, Zhu T, Characterization of fibrinogen-like protein 2 (FGL2): monomeric FGL2 has enhanced immunosuppressive activity in comparison to oligomeric FGL2. Int J Biochem Cell Biol 2013;45(2):408–418. doi: 10.1016/j.biocel.2012.10.014. PubMed PMID: 23127799.
  • McGilvray ID, Lu Z, Wei AC, Murine hepatitis virus strain 3 induces the macrophage prothrombinase fgl-2 through p38 mitogen-activated protein kinase activation. J Biol Chem 1998;273(48):32222–32229. PubMed PMID: 9822700.
  • Ning Q, Lakatoo S, Liu M, Induction of prothrombinase fgl2 by the nucleocapsid protein of virulent mouse hepatitis virus is dependent on host hepatic nuclear factor-4 alpha. J Biol Chem 2003;278(18):15541–15549. doi: 10.1074/jbc.M212806200. PubMed PMID: 12594208.
  • Ning Q, Liu M, Kongkham P, The nucleocapsid protein of murine hepatitis virus type 3 induces transcription of the novel fgl2 prothrombinase gene. J Biol Chem 1999;274(15):9930–9936. PubMed PMID: 10187767.
  • Han M, Yan W, Guo W, Hepatitis B virus-induced hFGL2 transcription is dependent on c-Ets-2 and MAPK signal pathway. J Biol Chem 2008;283(47):32715–32729. doi: 10.1074/jbc.M806769200. PubMed PMID: 18801734.
  • Liu Y, Xu L, Zeng Q, Downregulation of FGL2/prothrombinase delays HCCLM6 xenograft tumour growth and decreases tumour angiogenesis. Liver Int: Official J Int Assoc Study Liver 2012;32(10):1585–1595. doi: 10.1111/j.1478-3231.2012.02865.x. PubMed PMID: 22925132.
  • Robertson M. Fgl2: link between hepatitis B and SARS? Drug Discov Today 2003;8(17):768–770. PubMed PMID: 12946632.
  • Drosten C, Gunther S, Preiser W, Identification of a novel coronavirus in patients with severe acute respiratory syndrome. N Engl J Med 2003;348(20):1967–1976. doi: 10.1056/NEJMoa030747. PubMed PMID: 12690091.
  • Kohno T, Moriuchi R, Katamine S, Identification of genes associated with the progression of adult T cell leukemia (ATL). Jpn J Cancer Res 2000;91(11):1103–1110. Epub 2000/11/28. PubMed PMID: 11092974.
  • Auffermann-Gretzinger S, Keeffe EB, Levy S. Impaired dendritic cell maturation in patients with chronic, but not resolved, hepatitis C virus infection. Blood 2001;97(10):3171–3176. PubMed PMID: 11342445.
  • Hecht TT, Longo DL, Matis LA. The relationship between immune interferon production and proliferation in antigen-specific, MHC-restricted T cell lines and clones. J Immunol 1983;131(3):1049–1055. PubMed PMID: 6193170.
  • Everson MP, Spalding DM, Koopman WJ. Enhancement of IL-2-induced T cell proliferation by a novel factor(s) present in murine spleen dendritic cell-T cell culture supernatants. J Immunol 1989;142(4):1183–1194. PubMed PMID: 2644351.
  • Maraskovsky E, Chen WF, Shortman K. IL-2 and IFN-gamma are two necessary lymphokines in the development of cytolytic T cells. J Immunol 1989;143(4):1210–1214. PubMed PMID: 2501391.
  • Wagner F, Fischer N, Lersch C, Interleukin 4 inhibits the interleukin 2-induced production of its functional antagonist, interferon gamma. Immunol Lett 1989;21(3):237–241. PubMed PMID: 2504666.
  • Taga K, Tosato G. IL-10 inhibits human T cell proliferation and IL-2 production. J Immunol 1992;148(4):1143–1148. PubMed PMID: 1737931.
  • Han X, Itoh K, Balch CM, Pellis NR. Recombinant interleukin 4 (RIL4) inhibits interleukin 2-induced activation of peripheral blood lymphocytes. Lymphokine Res 1988;7(3):227–235. PubMed PMID: 3263554.
  • Fontenot JD, Rasmussen JP, Williams LM, Regulatory T cell lineage specification by the forkhead transcription factor foxp3. Immunity 2005;22(3):329–341. doi: 10.1016/j.immuni.2005.01.016. PubMed PMID: 15780990.
  • Miyara M, Sakaguchi S. Natural regulatory T cells: mechanisms of suppression. Trends Mol Med 2007;13(3):108–116. doi: 10.1016/j.molmed.2007.01.003. PubMed PMID: 17257897.
  • Fontenot JD, Rasmussen JP, Gavin MA, Rudensky AY. A function for interleukin 2 in Foxp3-expressing regulatory T cells. Nat Immunol 2005;6(11):1142–1151. doi: 10.1038/ni1263. PubMed PMID: 16227984.
  • Gavin MA, Rasmussen JP, Fontenot JD, Foxp3-dependent programme of regulatory T-cell differentiation. Nature 2007;445(7129):771–775. doi: 10.1038/nature05543. PubMed PMID: 17220874.
  • Xie L, Ichimaru N, Morita M, Identification of a novel biomarker gene set with sensitivity and specificity for distinguishing between allograft rejection and tolerance. Liver Transplantation: official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society. 2012;18(4):444–454. doi: 10.1002/lt.22480. PubMed PMID: 22162188.
  • Williams LM, Rudensky AY. Maintenance of the Foxp3-dependent developmental program in mature regulatory T cells requires continued expression of Foxp3. Nat Immunol 2007;8(3):277–284. doi: 10.1038/ni1437. PubMed PMID: 17220892.
  • Zheng Y, Josefowicz SZ, Kas A, Genome-wide analysis of Foxp3 target genes in developing and mature regulatory T cells. Nature 2007;445(7130):936–940. doi: 10.1038/nature05563. PubMed PMID: 17237761.
  • Belkaid Y, Rouse BT. Natural regulatory T cells in infectious disease. Nat Immunol 2005;6(4):353–360. doi: 10.1038/ni1181. PubMed PMID: 15785761.
  • Shalev I, Wong KM, Foerster K, The novel CD4+CD25+ regulatory T cell effector molecule fibrinogen-like protein 2 contributes to the outcome of murine fulminant viral hepatitis. Hepatology 2009;49(2):387–397. doi: 10.1002/hep.22684. PubMed PMID: 19085958.
  • Shalev I, Selzner N, Helmy A, The role of FGL2 in the pathogenesis and treatment of hepatitis C virus infection. Rambam Maimonides Med J 2010;1(1):e0004(1-12). doi: 10.5041/RMMJ.10004. PubMed PMID: 23908776; PubMed Central PMCID: PMC3721661.
  • Li Q, Smith AJ, Schacker TW, Microarray analysis of lymphatic tissue reveals stage-specific, gene expression signatures in HIV-1 infection. J Immunol 2009;183(3):1975–1982. doi: 10.4049/jimmunol.0803222. PubMed PMID: 19596987; PubMed Central PMCID: PMC3552354.
  • Han M, Yan W, Huang Y, The nucleocapsid protein of SARS-CoV induces transcription of hfgl2 prothrombinase gene dependent on C/EBP alpha. J Biochem 2008;144(1):51–62. doi: 10.1093/jb/mvn042. PubMed PMID: 18390877.
  • Liu H, Shalev I, Manuel J, The FGL2-FcgammaRIIB pathway: a novel mechanism leading to immunosuppression. Eur J Immunol 2008;38(11):3114–3126. doi: 10.1002/eji.200838338. PubMed PMID: 18991288.
  • Muta T, Kurosaki T, Misulovin Z, A 13-amino-acid motif in the cytoplasmic domain of Fc gamma RIIB modulates B-cell receptor signalling. Nature 1994;368(6466):70–73. doi: 10.1038/368070a0. PubMed PMID: 8107887.
  • Nadler MJ, Chen B, Anderson JS, Protein-tyrosine phosphatase SHP-1 is dispensable for FcgammaRIIB-mediated inhibition of B cell antigen receptor activation. J Biol Chem 1997;272(32):20038–20043. PubMed PMID: 9242674.
  • Tridandapani S, Pradhan M, LaDine JR, Protein interactions of Src homology 2 (SH2) domain-containing inositol phosphatase (SHIP): association with Shc displaces SHIP from FcgammaRIIb in B cells. J Immunol 1999;162(3):1408–1414. PubMed PMID: 9973396.
  • Jacob A, Cooney D, Tridandapani S, FcgammaRIIb modulation of surface immunoglobulin-induced Akt activation in murine B cells. J Biol Chem 1999;274(19):13704–13710. PubMed PMID: 10224144.
  • Ravetch JV, Bolland S. IgG Fc receptors. Ann Rev Immunol 2001;19:275–290. doi: 10.1146/annurev.immunol.19.1.275. PubMed PMID: 11244038.
  • Koski GK, Lyakh LA, Cohen PA, Rice NR. CD14+ monocytes as dendritic cell precursors: diverse maturation-inducing pathways lead to common activation of NF-kappab/RelB. Crit Rev Immunol 2001;21(1–3):179–189. PubMed PMID: 11642603.
  • Neumann M, Fries H, Scheicher C, Differential expression of Rel/NF-kappaB and octamer factors is a hallmark of the generation and maturation of dendritic cells. Blood 2000;95(1):277–285. PubMed PMID: 10607713.
  • Liu M, Mendicino M, Ning Q, Cytokine-induced hepatic apoptosis is dependent on FGL2/fibroleukin: the role of Sp1/Sp3 and STAT1/PU.1 composite cis elements. J Immunol 2006;176(11):7028–7038. PubMed PMID: 16709865.
  • Hancock WW, Szaba FM, Berggren KN, Intact type 1 immunity and immune-associated coagulative responses in mice lacking IFN gamma-inducible fibrinogen-like protein 2. Proc Nat Acad Sci USA 2004;101(9):3005–3010. doi: 10.1073/pnas.0308369101. PubMed PMID: 14976252; PubMed Central PMCID: PMC365735.
  • Levy GA, MacPhee PJ, Fung LS, The effect of mouse hepatitis virus infection on the microcirculation of the liver. Hepatology 1983;3(6):964–973. PubMed PMID: 6313508.
  • MacPhee PJ, Dindzans VJ, Fung LS, Levy GA. Acute and chronic changes in the microcirculation of the liver in inbred strains of mice following infection with mouse hepatitis virus type 3. Hepatology 1985;5(4):649–660. PubMed PMID: 2991107.
  • Parr RL, Fung L, Reneker J, Association of mouse fibrinogen-like protein with murine hepatitis virus-induced prothrombinase activity. J Virol 1995;69(8):5033–5038. PubMed PMID: 7609073; PubMed Central PMCID: PMC189320.
  • Fingerote RJ, Abecassis M, Phillips MJ, Loss of resistance to murine hepatitis virus strain 3 infection after treatment with corticosteroids is associated with induction of macrophage procoagulant activity. J Virol 1996;70(7):4275–4282. PubMed PMID: 8676449; PubMed Central PMCID: PMC190359.
  • Khattar R, Luft O, Yavorska N, Targeted deletion of FGL2 leads to increased early viral replication and enhanced adaptive immunity in a murine model of acute viral hepatitis caused by LCMV WE. PLoS One 2013;8(10):e72309(1-11). Epub 2013/10/23. doi: 10.1371/journal.pone.0072309 PONE-D-13-01283 [pii]. PubMed PMID: 24146739; PubMed Central PMCID: PMC3795679.
  • Pardoll DM. The blockade of immune checkpoints in cancer immunotherapy. Nat Rev Cancer 2012;12(4):252–264. doi: 10.1038/nrc3239. PubMed PMID: 22437870.
  • Cao D, Xu H, Guo G, Intrahepatic expression of programmed death-1 and its ligands in patients with HBV-related acute-on-chronic liver failure. Inflammation 2013;36(1):110–120. doi: 10.1007/s10753-012-9525-7. PubMed PMID: 22895698.
  • Cao D, Xu H, Guo G, Intrahepatic expression of programmed death-1 and its ligands in patients with HBV-related acute-on-chronic liver failure. Inflammation 2013;36(1):110–120. Epub 2012/08/17. doi: 10.1007/s10753-012-9525-7. PubMed PMID: 22895698.
  • Chen Y, Wu S, Guo G, Programmed death (PD)-1-deficient mice are extremely sensitive to murine hepatitis virus strain-3 (MHV-3) infection. PLoS Pathogens 2011;7(7):e1001347(1-12). doi: 10.1371/journal.ppat.1001347. PubMed PMID: 21750671; PubMed Central PMCID: PMC3131267.
  • Keir ME, Butte MJ, Freeman GJ, Sharpe AH. PD-1 and its ligands in tolerance and immunity. Ann Rev. Immunol 2008;26:677–704. doi: 10.1146/annurev.immunol.26.021607.090331. PubMed PMID: 18173375.
  • Foerster K, Helmy A, Zhu Y, The novel immunoregulatory molecule FGL2: a potential biomarker for severity of chronic hepatitis C virus infection. J Hepatol 2010;53(4):608–615. doi: 10.1016/j.jhep.2010.04.020. PubMed PMID: 20615566.
  • Li C, Fung LS, Chung S, Monoclonal antiprothrombinase (3D4.3) prevents mortality from murine hepatitis virus (MHV-3) infection. J Exp Med 1992;176(3):689–697. PubMed PMID: 1324969; PubMed Central PMCID: PMC2119354.
  • Pope M, Rotstein O, Cole E, Pattern of disease after murine hepatitis virus strain 3 infection correlates with macrophage activation and not viral replication. J Virol 1995;69(9):5252–5260. PubMed PMID: 7636967; PubMed Central PMCID: PMC189358.
  • Selzner N, Liu H, Boehnert MU, FGL2/fibroleukin mediates hepatic reperfusion injury by induction of sinusoidal endothelial cell and hepatocyte apoptosis in mice. J Hepatol 2012;56(1):153–159. doi: 10.1016/j.jhep.2011.05.033. PubMed PMID: 21756857.
  • Chen T, Ye X, Huang Z, Fgl2 prothrombinase is involved in severe acute pancreatitis-associated liver injury. Hepato-gastroenterology 2012;59(116):1225–1229. doi: 10.5754/hge12117. PubMed PMID: 22456282.
  • Chen WJ, Yang JY, Lin JH, Nasopharyngeal shedding of severe acute respiratory syndrome-associated coronavirus is associated with genetic polymorphisms. Clin Infectious Diseases (an official publication of the Infectious Diseases Society of America) 2006;42(11):1561–1569. doi: 10.1086/503843. PubMed PMID: 16652313.
  • De Albuquerque N, Baig E, Ma X, Murine hepatitis virus strain 1 produces a clinically relevant model of severe acute respiratory syndrome in A/J mice. J Virol 2006;80(21):10382–10394. doi: 10.1128/JVI.00747-06. PubMed PMID: 17041219; PubMed Central PMCID: PMC1641767.
  • Zhu C, Sun Y, Luo X, Novel mfgl2 antisense plasmid inhibits murine fgl2 expression and ameliorates murine hepatitis virus type 3-induced fulminant hepatitis in BALB/cJ mice. Human Gene Therapy 2006;17(6):589–600. doi: 10.1089/hum.2006.17.589. PubMed PMID: 16776568.
  • Gao S, Wang M, Ye H, Dual interference with novel genes mfgl2 and mTNFR1 ameliorates murine hepatitis virus type 3-induced fulminant hepatitis in BALB/cJ mice. Human gene Therapy 2010;21(8):969–977. doi: 10.1089/hum.2009.177. PubMed PMID: 20218879.
  • Bach FH, Winkler H, Ferran C, Delayed xenograft rejection. Immunol Today 1996;17(8):379–384. PubMed PMID: 8783499.
  • Ghanekar A, Mendicino M, Liu H, Endothelial induction of fgl2 contributes to thrombosis during acute vascular xenograft rejection. J Immunol 2004;172(9):5693–5701. PubMed PMID: 15100314.
  • Mendicino M, Liu M, Ghanekar A, Targeted deletion of Fgl-2/fibroleukin in the donor modulates immunologic response and acute vascular rejection in cardiac xenografts. Circulation 2005;112(2):248–256. doi: 10.1161/CIRCULATIONAHA.105.534271. PubMed PMID: 15998670.
  • Ning Q, Sun Y, Han M, Role of fibrinogen-like protein 2 prothrombinase/fibroleukin in experimental and human allograft rejection. J Immunol 2005;174(11):7403–7411. PubMed PMID: 15905589.
  • Clark DA, Chaouat G, Arck PC, Cytokine-dependent abortion in CBA × DBA/2 mice is mediated by the procoagulant fgl2 prothrombinase [correction of prothombinase]. J Immunol 1998;160(2):545–549. PubMed PMID: 9551885.
  • Knackstedt M, Ding JW, Arck PC, Activation of the novel prothrombinase, fg12, as a basis for the pregnancy complications spontaneous abortion and pre-eclampsia. Am J Reprod Immunol 2001;46(3):196–210. PubMed PMID: 11554693.
  • Clark DA, Foerster K, Fung L, The fgl2 prothrombinase/fibroleukin gene is required for lipopolysaccharide-triggered abortions and for normal mouse reproduction. Mol Hum Reprod 2004;10(2):99–108. PubMed PMID: 14742694.
  • Foerster K, He W, Manuel J, LPS-induced occult loss in mice requires FGL2. Am J Reproduct Immunol 2007;58(6):524–529. doi: 10.1111/j.1600-0897.2007.00543.x. PubMed PMID: 17997751.
  • Liu Y, Xu S, Xiao F, The FGL2/fibroleukin prothrombinase is involved in alveolar macrophage activation in COPD through the MAPK pathway. Biochem Biophys Res Commun 2010;396(2):555–561. doi: 10.1016/j.bbrc.2010.04.145. PubMed PMID: 20438701.
  • Young A, Chapman O, Connor C, Thrombosis and cancer. Nat Rev Clin Oncol 2012;9(8):437–449. doi: 10.1038/nrclinonc.2012.106. PubMed PMID: 22777060.
  • Kawakami Y, Yaguchi T, Sumimoto H, Cancer-induced immunosuppressive cascades and their reversal by molecular-targeted therapy. Ann NY Acad Sci 2013;1284:80–86. doi: 10.1111/nyas.12094. PubMed PMID: 23651199.
  • Birkhauser FD, Koya RC, Neufeld C, Dendritic cell-based immunotherapy in prevention and treatment of renal cell carcinoma: efficacy, safety, and activity of Ad-GM.CAIX in immunocompetent mouse models. J Immunother 2013;36(2):102–111. Epub 2013/02/05. doi: 10.1097/CJI.0b013e31827bec97. PubMed PMID: 23377663.
  • Liu Y, Xu L, Zeng Q, Downregulation of FGL2/prothrombinase delays HCCLM6 xenograft tumour growth and decreases tumour angiogenesis. Liver Int 2012. Epub 2012/08/29. doi: 10.1111/j.1478-3231.2012.02865.x. PubMed PMID: 22925132.
  • van Hinsbergh VW, Collen A, Koolwijk P. Role of fibrin matrix in angiogenesis. Ann NY Acad Sci 2001;936:426–437. Epub 2001/07/20. PubMed PMID: 11460496.
  • Maragoudakis ME, Tsopanoglou NE, Andriopoulou P. Mechanism of thrombin-induced angiogenesis. Biochem Soc Trans 2002;30(2):173–177. Epub 2002/05/25. doi: 10.1042/. PubMed PMID: 12023846.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.